Rosario Lobrutto, PhD, MBA, MS has served as Vice President, Global Head of Technical Operations since April 2024. Dr. Lobrutto has over 25 years of global leadership experience across R&D, Manufacturing/Technology, Business Development & Licensing (BD&L), and strategic growth in Fortune 200/500 companies such as Merck, Novartis, TEVA, and Sandoz.
Prior to joining Ironwood, he served as Head of Pharmaceutical Sciences/CMC and Global Expansion at Radius Health, where he played a key role in advancing patient-centric innovative medicines. His career includes the successful development and launch of both innovative and generic medicines, with a particular focus on injectables. Dr. Lobrutto has contributed to over 40 regulatory submissions and numerous product launches, demonstrating deep expertise in API and Drug Product Development, including small molecules, peptides, and proteins. He has a proven track record in driving innovation, portfolio strategy, operational excellence, and implementing QbD/Lean initiatives.
Dr. Lobrutto completed his undergraduate degree in Chemistry from Drexel University and Ph.D. in Analytical Chemistry from Seton Hall University. He completed his MBA from the Cornell Johnson Graduate School of Management with distinction and his MS in Health Care Policy and Leadership from the Weill Cornell Graduate School of Medical Sciences.